Sheel Biotech Ltd.

NSE: SHEEL

Sheel Biotech Live Share Price Today, Share Analysis and Chart

Name: Sheel Biotech Ltd.: Is Infosys Ltd. worth buying?
Item: Sheel Biotech Ltd.
Rating: 1.70258325
Author: Trendlyne DVM scores

aboutSC Agrotech Ltd. (formerly known as Sheel International Limited) is an Indian enterprise operating primarily in the agricultural and trading sectors. The company specializes in the trading and manufacturing of agricultural products, including activit... Read More

-2.05(-3.49%)

30.06% Fall from 52W High

6,000

NSE Volume

NSE 29 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

- / 100

39.3 / 100

No estimates available

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

Medium rank

5Positive10Negative

33.3%Pass in checklist

045

100

Check P/E Buy Sell Zone

Strong Sell Zone

100.0 % into P/E buy sell zone

% time spent below current P/E

020406080100

Strong upside potential

Gains already realized

Sheel Biotech Stock Price Analysis

Day Price Range -3.5% 1 Day return	56.6 (LTP) 56.256.6 LowHigh
Week Price Range -3.9% 1 Week return	56.6 (LTP) 56.258.7 LowHigh
Month Price Range -5.9% 1 Month return	56.6 (LTP) 56.263 LowHigh
52 Week Price Range -29.2% 1 Year return	56.6 (LTP) 37.881 LowHigh

View full Price History/Seasonality

Competitors/Peers

Annual

Balance Sheet

Ratios

Cash Flow

Documents

Sheel Biotech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Sheel Biotech Mar-2026 Annual Revenue is Rs 111 Cr which is growth of 8.3% YoY.
POSITIVE
Annual Net Profit Sheel Biotech Mar-2026 Annual Net Profit is Rs 12 Cr which is growth of 10.5% YoY.

Sheel Biotech Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22
SR_A Total Rev. Ann. ⌄	11.3%	110.7	102.3	92.6	80.2	71.1
TotalOperatingRevenues_A Operating Rev. Ann.	11.2%	110	101.8	92.3	80.1	70.7
OI_A Other Income Ann.	91.3%	0.7	0.5	0.3	0.1	0.3
OEXPNS_A Operating Exp. Ann.	9.5%	93.7	86.8	77.8	71.3	64.4
OEXPNS_A Operating Exp. Ann.	9.5%	93.7	86.8	77.8	71.3	64.4
OP_A Operating Profit Ann.	22.8%	16.3	15	14.5	8.8	6.4
OPMPCT_A OPM Ann. %	10.1%	14.71%	14.64%	15.62%	11.01%	8.98%
TotalExpenses_A Total Exp. Ann. ⌄	9.4%	96.7	89.5	80.3	73.8	66.5
OtherExpenses_A Other Exp. Ann.	9.7%	11.1	8.2	8.9	8.4	7.7
EmployeeBenefitExpenses_A Employee Exp. Ann.	14.5%	14.7	13.5	12	9.8	9.5
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-
CostOfFuel_A Cost Of Fuel Ann.	-
EBIDT_A EBITDA Ann.	24.1%	17	15.5	14.7	8.9	6.7
EBIDTPCT_A EBITDA Ann. margin %	11.4%	15.35%	15.15%	15.90%	11.11%	9.45%
INT_A Interest Ann.	8.2%	1.9	1.8	1.5	1.5	1.2
DEP_A Depr.	3.2%	1.1	0.9	1	1	0.9
PBT_A PBT Ann.	29.8%	14	12.8	12.3	6.4	4.6
TAX_A Tax Ann.	20.9%	2.3	2.2	1.7	1.3	0.1
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	32.3%	11.8	10.6	10.5	5.1	4.5
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-	-	-	-	-
NP_A Net Profit Ann.	32.3%	11.8	10.6	10.5	5.1	4.5
NETPCT_A NPM Ann. %	19%	10.68%	10.45%	11.38%	6.33%	6.37%
EPS_adj_A EPS Adj. latest Ann.	32.4%	5.8	5.2	5.2	2.5	2.2

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

VIEW ALL TABLE IN FINANCIAL PAGE

Total Rev. Ann.

1Y CHG

8.2%

2Y CAGR

9.3%

3Y CAGR

11.3%

Net Profit Ann.

1Y CHG

11.3%

2Y CAGR

3Y CAGR

32.3%

Operating Exp. Ann.

1Y CHG

7.9%

2Y CAGR

9.7%

3Y CAGR

9.5%

Sheel Biotech Technical Analysis

Sheel Biotech EMA & SMA

Bearish-8

0 bullish, 8 bearish

Bullish0

Bearish8

5 Day	58.6
10 Day	59.4
12 Day	59.6
20 Day	60.2

26 Day	60.6
50 Day	61.2
100 Day	61.0
200 Day	63.0

Sheel Biotech Delivery And Volume

Daily Avg. Delivery Volume %

29 Oct, 2026100.0%

Week100.0%

Month-

Sheel Biotech Active Candlesticks

Hikkake Uptrend Short Line Uptrend

Legend

Positive IndicatorNeutral IndicatorNegative Indicator

Sheel Biotech Resistance and Support

56.48

Pivot

First Resistance	56.8
Second Resistance	57.0
Third Resistance	57.3

First Support	56.3
Second Support	56.0
Third Support	55.8

Day RSI	39.8
Day MACD	-1
Day MFI	74.7
Day MACD Signal Line	-0.8

Sheel Biotech Beta

1 Month	-0.1
1 Year	-

3 Month	0.5
3 Year	-

Sheel Biotech Price Change Analysis

↓-5.9%

Over 1 Month

LowHigh

56.263

↓-16.7%

Over 3 Months

LowHigh

56.268.5

↑21.4%

Over 6 Months

LowHigh

39.175.4

↓-29.2%

Over 1 Year

LowHigh

37.881

Sheel Biotech Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026

Name	Category	Shares	Shares %
Sanjay Chandak	Promoter	3,982,375	19.6 %
Bakul Chaturbhai Limbasiya	Public	324,000	1.6 %
Aarth Aif Growth Fund	Dii	888,000	4.4 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Sheel Biotech Deals - Insider, Bulk, Block and SAST

Client Name	Deal Type	Action	Date	Avg. Price	Quantity	Exchange
BAKUL CHATURBHAI LIMBASIYA	Bulk	Purchase	18 Jun 2026	72.90	150,000	NSE
SHUBHAM SANJAY DAMANI	Bulk	Sell	16 Feb 2026	63.57	116,000	NSE
LONGVIEW RESEARCH AND ADVISORY SERVICES PRIVATE LIMITED	Bulk	Purchase	16 Feb 2026	63.33	102,000	NSE
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	Sell	13 Oct 2025	82	60,000	NSE
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	Purchase	13 Oct 2025	82	130,000	NSE
LONGTHRIVE CAPITAL VCC - GAMMA VIEW FUNDS	Bulk	Sell	08 Oct 2025	91.23	106,000	NSE
CRAFT EMERGING MARKET FUND PCC- CITADEL CAPITAL FUND	Bulk	Sell	08 Oct 2025	91	136,000	NSE
MANSI SHARE AND STOCK BROKING PRIVATE LIMITED	Bulk	Sell	08 Oct 2025	92.06	122,000	NSE
SMP SECURITIES LTD	Bulk	Purchase	08 Oct 2025	91	112,000	NSE
PREETI BHAUKA	Bulk	Purchase	08 Oct 2025	91	134,000	NSE

All deals

All insider trades

Sheel Biotech Corporate Actions

Sheel Biotech Board Meetings

Sheel Biotech past and upcoming board meetings.

#Ex-Date	Purpose	Notes
131 Aug 2026	Other business matters	-
228 May 2026	Audited Results	-
315 Nov 2025	Quarterly Results	(Revised)

All Corporate Actions

Sheel Biotech - Company Profile

Sheel Biotech Management Structure

Sheel Biotech management structure with salaries, total experience, and qualifications.

NAME	DESIGNATION	GROSS REMUNERATION ₹(LAC)	AS OF	HISTORY & DETAILS
Anupam pandey	Company Secretary,Compliance Officer	-	Mar 26

Sheel Biotech Board of Directors

Sheel Biotech Board of directors with salaries, total experience, and qualifications.

NAME	POSITION	GROSS REMUNERATION ₹(LAC)	AS OF
Sanjay Chandak	Executive Director	90	Mar 25
SATYA NARAYAN CHANDAK	Chairman & Exec. Director	72	Mar 25
Divye Chandak	Executive Director & MD	30	Mar 25
Anupam pandey	Company Sec. & Compli. Officer	0.85	Mar 25
Mini Chadha	Independent Non Exe. Director	-	Mar 25
Ramesh Chandra Srivastava	Independent Non Exe. Director	-	Mar 25
Shyamsundar Bang	Independent Non Exe. Director	-	Mar 25
Atul Kumar	Independent Non Exe. Director	-	Mar 25

About

Website: www.sheelbiotech.com

About the company - Business Profile

SC Agrotech Ltd. (formerly known as Sheel International Limited) is an Indian enterprise operating primarily in the agricultural and trading sectors. The company specializes in the trading and manufacturing of agricultural products, including activities related to seeds, tissue culture, and agro-based commodities. Over recent years, the company has undergone significant corporate shifts, including a name change from Sheel International Limited to SC Agrotech Limited, reflecting a broader strategic focus within the agrotech industry.

Key Points

Key Facts

Founded Year: 1990
Headquarters: New Delhi, India
Company Name: SC Agrotech Ltd. (Formerly Sheel International Limited)
Stock Listing: BSE Limited (Scrip Code: 526081)
Registrar and Share Transfer Agent: Skyline Financial Services Pvt. Ltd.

Operations and Resources

Registered Office: Rz-1484/28, Ground Floor, Tughlakabad Extension, New Delhi - 110019.
Corporate Office: Office No. 509, Fifth Floor, I-Square, Science City Road, Sola, Ahmedabad, Gujarat.
Assets: The company reported Property, Plant and Equipment valued at ₹112.98 lakhs as of March 31, 2025. Total assets stood at ₹313.80 lakhs for the same period.

Business Model and Segment Performance

Business Model: The company operates a trading and manufacturing model focused on the agricultural sector. It generates revenue through the sale of agro-commodities and related biological assets.
Revenue Breakdown (FY 2024-25):
- Revenue from Operations: ₹247.33 lakhs (Audited, for the year ended March 31, 2025).
- Other Income: ₹0.00 lakhs in the audited FY25 report, though quarterly results for December 2025 showed substantial variations in other income during the nine-month period.
Quarterly Performance (December 2025): For the quarter ended December 31, 2025, the company reported a significant surge in Revenue from Operations to ₹3,756.05 lakhs, compared to ₹501.69 lakhs in the preceding quarter (September 2025).

Financial Highlights (FY 2024-25)

Total Revenue: ₹247.33 lakhs.
Total Expenses: ₹228.40 lakhs.
Profit Before Tax: ₹18.93 lakhs.
Profit After Tax (PAT): ₹18.93 lakhs (for the year ended March 31, 2025).
Earnings Per Share (EPS): ₹0.32 (Basic and Diluted).

Management and Governance

Managing Director: Pratikkumar Bharatbhai Patel.
Executive Director: Suchitkumar Bipinchandra Patel.
Chief Financial Officer: Jeet Paragkumar Patel.
Company Secretary: Ritika Sood.

Strategic Initiatives and Future Outlook

The company is focused on scaling its trading operations, as evidenced by the sharp increase in stock-in-trade purchases, which reached ₹5,924.42 lakhs in the quarter ended December 2025.
Strategic shifts include enhancing geographic presence with a corporate office in Ahmedabad to oversee operations in the Gujarat region.
Current efforts are directed toward stabilizing operating margins while managing a larger volume of agricultural trade.

References

Sheel Biotech FAQ

Sheel Biotech today is trading in the red, down by 3.49% at ₹56.65.

Sheel Biotech is currently trading down 3.49% on an intraday basis. In the past week the stock fell 3.9%. Stock has been down 16.69% in the past quarter and fell 29.19% in the past year. You can view this in the share price history/seasonality section.

Sheel Biotech is listed on NSE with the ticker SHEEL. It's currently trading on NSE at a share price of ₹56.65.

The market cap of Sheel Biotech is ₹115.3 Cr. as of Oct 29, 2026.

Sheel Biotech has never announced any dividend since the time of its listing on the NSE exchange.

Sheel Biotech has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

Sheel Biotech reported ₹110.74 Cr. in revenue, ₹11.76 Cr. in net profit, and ₹17 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

There are no analyst predictions for stock price target for Sheel Biotech.

The PE ratio of Sheel Biotech is 9.81 as of Oct 29, 2026.

The PB ratio of Sheel Biotech is 0.91 as of Oct 29, 2026.

There are no analyst reports for Sheel Biotech.

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.

Key Metrics
DVM
Price Chart
Forecaster
Financials
Technicals
Shareholding
Deals
Documents
Corporate actions
Company Profile

Sheel Biotech Live Share Price Today, Share Analysis and Chart

SWOT Analysis

Check Before You Buy

Check P/E Buy Sell Zone

Sheel Biotech Stock Price Analysis

Day Price Range

Week Price Range

Month Price Range

52 Week Price Range

Sheel Biotech - Annual

Sheel Biotech annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Annual Revenue Sheel Biotech Mar-2026 Annual Revenue is Rs 111 Cr which is growth of 8.3% YoY.

Annual Net Profit Sheel Biotech Mar-2026 Annual Net Profit is Rs 12 Cr which is growth of 10.5% YoY.

Sheel Biotech Technical Analysis

Sheel Biotech EMA & SMA

Sheel Biotech Delivery And Volume

Sheel Biotech Active Candlesticks

Sheel Biotech Resistance and Support

Sheel Biotech Beta

Sheel Biotech Price Change Analysis

Sheel Biotech Shareholding Pattern/ Ownership

Shareholding Summary

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Sheel Biotech Deals - Insider, Bulk, Block and SAST

Bulk Block Deals

Insider Trading & SAST

Sheel Biotech Corporate Actions

Sheel Biotech Board Meetings

Sheel Biotech past and upcoming board meetings.

Sheel Biotech - Company Profile

Sheel Biotech Management Structure

Sheel Biotech management structure with salaries, total experience, and qualifications.

Sheel Biotech Board of Directors

Sheel Biotech Board of directors with salaries, total experience, and qualifications.

About the company - Business Profile

Key Points

Sheel Biotech FAQ

How is Sheel Biotech today?

Sheel Biotech today is trading in the red, down by 3.49% at ₹56.65.

How has Sheel Biotech performed historically?

Sheel Biotech is currently trading down 3.49% on an intraday basis. In the past week the stock fell 3.9%. Stock has been down 16.69% in the past quarter and fell 29.19% in the past year. You can view this in the share price history/seasonality section.

What is the current share price of Sheel Biotech on NSE and BSE exchanges?

Sheel Biotech is listed on NSE with the ticker SHEEL. It's currently trading on NSE at a share price of ₹56.65.

What is the market cap of Sheel Biotech?

The market cap of Sheel Biotech is ₹115.3 Cr. as of Oct 29, 2026.

When did Sheel Biotech last pay a dividend, and what has its dividend history been?

Sheel Biotech has never announced any dividend since the time of its listing on the NSE exchange.

Has Sheel Biotech issued any bonus shares or share splits recently?

Sheel Biotech has never issued stock splits or bonus shares since the time of its listing on the NSE exchange.

What do the financial statements and annual reports of Sheel Biotech Indicate?

Sheel Biotech reported ₹110.74 Cr. in revenue, ₹11.76 Cr. in net profit, and ₹17 Cr. in EBITD as of Mar 31, 2026 for FY25-26.

What is the target share price of Sheel Biotech according to analyst predictions in FY26-27?

There are no analyst predictions for stock price target for Sheel Biotech.

What is the PE Ratio of Sheel Biotech?

The PE ratio of Sheel Biotech is 9.81 as of Oct 29, 2026.

What is the PB Ratio of Sheel Biotech?

The PB ratio of Sheel Biotech is 0.91 as of Oct 29, 2026.

Where can I check the latest Research Reports about Sheel Biotech?

There are no analyst reports for Sheel Biotech.

How can I be notified of real time alerts about Sheel Biotech stock?

You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.